Header Logo

Connection

JOHN KIRKWOOD to Picibanil

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Picibanil.
JOHN KIRKWOOD
Connection Strength
0.141
Picibanil
  1. Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma. Cancer Immunol Immunother. 1997 May; 44(3):137-49.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.